You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
哈藥股份(600664.SH):在產在銷的用於治療支原體肺炎的產品包括克拉黴素分散片等
格隆匯 12-05 19:22

格隆匯12月5日丨哈藥股份(600664.SH)在投資者互動平台表示,公司積極響應國家集採政策,2023年11月6日,分公司哈藥集團製藥總廠產品注射用鹽酸頭孢替安擬中標第九批國家組織藥品集中採購,中選品種簽訂購銷合同並實施後,將有利於提高中選產品的市場佔有率,提升公司的品牌影響力,對公司的長遠發展將產生積極的影響。 公司在產在銷的用於治療支原體肺炎的產品包括克拉黴素分散片、羅紅黴素分散片、注射用乳糖酸阿奇黴素等,具體用藥還需遵醫囑。上述產品在等級醫療、基層診療、零售藥店均有銷售。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account